These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 635819)

  • 1. [Catamnestic-statistical results of Proresid treatment of malignant tumors].
    Trüb CL; Pohlschmidt L
    Ther Ggw; 1978 Mar; 117(3):358-76. PubMed ID: 635819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with podophyllotoxin in the treatment of condylomata acuminata].
    Huwyler T; Gütling M; Panizzon R
    Schweiz Rundsch Med Prax; 1989 Feb; 78(8):186-90. PubMed ID: 2922513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant products in cancer chemotherapy.
    Carter SK; Livingston RB
    Cancer Treat Rep; 1976 Aug; 60(8):1141-56. PubMed ID: 791484
    [No Abstract]   [Full Text] [Related]  

  • 4. [Colchicine-podophyllotoxin combination in the treatment of preepithelial sevorrhoideal and cutaneous epitheliomas].
    Marrón Gasca J; Giménez Serrano H; Calvo Morales A; Moreno Garcés F
    Actas Dermosifiliogr; 1974; 65(7-8):388-94. PubMed ID: 4455060
    [No Abstract]   [Full Text] [Related]  

  • 5. The International Symposium on the Podophyllotoxins in Cancer Therapy, Southhampton, England, July 8-9, 1981.
    Cancer Chemother Pharmacol; 1982; 7(2-3):73-243. PubMed ID: 7083464
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phase II study of VP-16 (capsule) in solid tumors. A cooperative study].
    Honma T; Ogawa M; Yoshida S; Meguro S; Hirano M; Hoshino A; Shirakawa S; Nakamura T; Fukuoka M; Toki H
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):309-13. PubMed ID: 2982332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study of VP-16 (capsule) in malignant lymphomas. A cooperative study].
    Sampi K; Ogawa M; Maekawa T; Takaku F; Kuraishi Y; Ota K; Hirano M; Hoshino A; Shirakawa S; Kimura I
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):314-9. PubMed ID: 3970554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute monocytic and myelomonocytic leukemias. Incidence and treatment with an epipodophyllotoxin derivative (VP 16.213)].
    Bernasconi C; Lazzarino M; Morra E
    Recenti Prog Med; 1975 Oct; 59(4):372-87. PubMed ID: 769106
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppressive treatment of rheumatologic diseases].
    Olhagen B
    Lakartidningen; 1976 Apr; 73(17):1628-33. PubMed ID: 1083469
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of malignant tumors with SP-I/SP-G Sandoz (Proresid)].
    Bîrzu I
    Ther Umsch; 1966 Dec; 23(12):522-7. PubMed ID: 5980440
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of podophyllotoxin for the treatment of genital warts.
    Beutner KR; von Krogh G
    Semin Dermatol; 1990 Jun; 9(2):148-51. PubMed ID: 2202410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary report of podophyllotoxin in the treatment of genital warts in China].
    Wang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Apr; 13(2):152-4. PubMed ID: 1831715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [General principles and new trends of cytostatic tumor therapy].
    Holfeld H; Bamberg M
    Strahlentherapie; 1980 May; 156(5):297-307. PubMed ID: 7190333
    [No Abstract]   [Full Text] [Related]  

  • 14. Inflammatory parameters in rheumatoid arthritis during and after administration of an anti-mitotic agent (Podophyllum lignan derivatives).
    Berglund K; Johansson BG; Laurell AB; Sjöholm A; Sturfelt G
    Scand J Rheumatol; 1978; 7(1):61-3. PubMed ID: 675176
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of VM-26 in adult malignancies.
    Spremulli E; Schulz JJ; Speckhart VJ; Wampler GL
    Cancer Treat Rep; 1980 Jan; 64(1):147-9. PubMed ID: 7379049
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time].
    Chatelut E; Canal P; De Forni M; Chevreau C; Houin G; Bugat R
    Bull Cancer; 1989; 76(8):893-6. PubMed ID: 2620120
    [No Abstract]   [Full Text] [Related]  

  • 17. VP-16-213. A phase II trial using a weekly schedule.
    Karp G; Antman K; Canellos G
    Cancer Clin Trials; 1981; 4(4):465-7. PubMed ID: 7318129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The successful treatment of molluscum contagiosum with podophyllotoxin (0.5%) self-application.
    Markos AR
    Int J STD AIDS; 2001 Dec; 12(12):833. PubMed ID: 11791521
    [No Abstract]   [Full Text] [Related]  

  • 19. [Platinum derivatives in the clinical chemotherapy of malignant tumors].
    Gorbunova VA
    Vopr Onkol; 1982; 28(5):38-43. PubMed ID: 7201207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of endoscopic therapy of anal canal condylomata acuminata with podophyllotoxin.
    Tzathas C; Stavrianeas NG; Triantafyllou K; Triantafyllou G; Ladas SD
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):364-7. PubMed ID: 17309460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.